Luminor Medical Technologies
Luminor Medical Technologies is a Canadian medical diagnostic company that specializes in the acquisition, development, and commercialization of non-invasive tests aimed at addressing unmet clinical needs. The company's notable products include the PREVU Skin Cholesterol Test, which evaluates cholesterol levels in skin tissues to assess the risk of coronary artery disease, and PSP94, an enzyme-linked immunosorbent assay designed for urine samples. Luminor is also developing diagnostic programs targeting conditions such as cardiovascular disease, preeclampsia, and various cancers, including prostate, colorectal, pancreatic, and gastric cancers. Furthermore, the company has established a partnership with Alere, Inc. to advance the development of tests for preeclampsia biomarkers.
Top Regions
Top Stages
https://crunchbase.com/organization/***
2 past transactions
VeraLight
Acquisition in 2013
VeraLight is a medical device company founded in October 2004, specializing in non-invasive screening for type 2 diabetes and pre-diabetes through its proprietary SCOUT DS system. The company aims to combat the global diabetes epidemic by promoting early detection of the disease, facilitating timely intervention and therapy to prevent diabetes or mitigate its complications. VeraLight is dedicated to developing and acquiring intellectual property, products, and services that align with its mission of enhancing diabetes screening and management.
Europroteome AG
Acquisition in 2005
Europroteome AG develops diagnostic, immunological, and prognostic tools as well as patient-specific therapies for human epithelial cancers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.